Disarm Therapeutics

Pheno Therapeutics

This biotech company develops neuroprotective and remyelinating therapies for patients with multiple sclerosis and other neurodegenerative disorders.

Progentos Therapeutics

The company develops small-molecule drugs to regenerate myelin for the treatment of patients with multiple sclerosis.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Samsara Therapeutics

This company develops autophagy-activating small molecule therapeutics to treat neurodegenerative and age-related diseases for patients with conditions such as ALS and Parkinson’s.

NRG Therapeutics

This neuroscience company develops small molecule medicines targeting mitochondrial dysfunction to treat patients with Parkinson's and amyotrophic lateral sclerosis.

Autobahn Therapeutics

This company develops brain-penetrating small molecule therapies for patients with neuropsychiatric and neuroimmunologic disorders, including depression and multiple sclerosis.

Ribonaut Therapeutics

Ribonaut Therapeutics develops small molecule drugs that target and degrade disease-causing RNA to treat neurological conditions and movement disorders for human patients.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.